{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:52:42Z","timestamp":1791330762572,"version":"4.3.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T00:00:00Z","timestamp":1783814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["(File No. BMS\/FW\/NANO\/FEB.2015; IRIS ID: 2014-25910)."],"award-info":[{"award-number":["(File No. BMS\/FW\/NANO\/FEB.2015; IRIS ID: 2014-25910)."]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-026-02243-y","type":"journal-article","created":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T07:04:01Z","timestamp":1783839841000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ferroptosis-associated immune modulation enhances temozolomide efficacy in experimental glioblastoma: potential implications for T-cell infiltration and tumour microenvironment dynamics"],"prefix":"10.1007","volume":"26","author":[{"given":"Shaik","family":"Rahaman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roli","family":"Kushwaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Vohora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumana","family":"Chakravarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4107-1775","authenticated-orcid":false,"given":"Ahmed","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,12]]},"reference":[{"key":"2243_CR1","doi-asserted-by":"crossref","unstructured":"Wang G, Wang W. Advanced Cell Therapies for Glioblastoma. Front. Immunol. 2022, 13.","DOI":"10.3389\/fimmu.2022.904133"},{"key":"2243_CR2","doi-asserted-by":"crossref","unstructured":"Angom RS, Nakka NMR, Bhattacharya S. Advances in Glioblastoma Therapy: An Update on Current Approaches. Brain Sci 2023, 13.","DOI":"10.3390\/brainsci13111536"},{"key":"2243_CR3","doi-asserted-by":"publisher","unstructured":"Wu H, Gao W, Chen P, Wei Y, Zhao H, Wang F. Research Progress of Drug Resistance Mechanism of Temozolomide in the Treatment of Glioblastoma. Heliyon 2024, 10, e39984. https:\/\/doi.org\/10.1016\/J.HELIYON.2024.E39984","DOI":"10.1016\/J.HELIYON.2024.E39984"},{"key":"2243_CR4","doi-asserted-by":"publisher","first-page":"817","DOI":"10.2174\/1871527321666220404180944\/CITE\/REFWORKS","volume":"22","author":"V Rao","year":"2022","unstructured":"Rao V, Kumar G, Vibhavari RJA, Nandakumar K, Thorat ND, Chamallamudi MR, Kumar N. Temozolomide Resistance: A Multifarious Review on Mechanisms Beyond O-6-Methylguanine-DNA Methyltransferase. CNS Neurol Disord Drug Targets. 2022;22:817\u201331. https:\/\/doi.org\/10.2174\/1871527321666220404180944\/CITE\/REFWORKS.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"2243_CR5","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2174\/1570159X18666200626204005\/CITE\/REFWORKS","volume":"19","author":"R Ortiz","year":"2020","unstructured":"Ortiz R, Perazzoli G, Cabeza L, Jim\u00e9nez-Luna C, Luque R, Prados J, Melguizo C. Temozolomide: An Updated Overview of Resistance Mechanisms, Nanotechnology Advances and Clinical Applications. Curr Neuropharmacol. 2020;19:513\u201337. https:\/\/doi.org\/10.2174\/1570159X18666200626204005\/CITE\/REFWORKS.","journal-title":"Curr Neuropharmacol"},{"key":"2243_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/S10238-025-01631-0","volume":"25","author":"MS Anwer","year":"2025","unstructured":"Anwer MS, Abdel-Rasol MA, El-Sayed WM. Emerging Therapeutic Strategies in Glioblastsoma: Drug Repurposing, Mechanisms of Resistance, Precision Medicine, and Technological Innovations. Clin Exp Med. 2025;25:117. https:\/\/doi.org\/10.1007\/S10238-025-01631-0.","journal-title":"Clin Exp Med"},{"key":"2243_CR7","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/S41419-025-07822-7","volume":"16","author":"X Liu","year":"2025","unstructured":"Liu X, Zeng L, Liu J, Huang Y, Yao H, Zhong J, Tan J, Gao X, Xiong D, Liu L. Artesunate Induces Ferroptosis in Diffuse Large B-Cell Lymphoma Cells by Targeting PRDX1 and PRDX2. Cell Death Dis. 2025;16:513. https:\/\/doi.org\/10.1038\/S41419-025-07822-7.","journal-title":"Cell Death Dis"},{"key":"2243_CR8","doi-asserted-by":"publisher","first-page":"e28584","DOI":"10.1016\/J.HELIYON.2024.E28584","volume":"10","author":"D Xiong","year":"2024","unstructured":"Xiong D, Geng C, Zeng L, Yao H, Tan J, Zhang L, Liu X, Liu L. Artesunate Induces Ferroptosis by Regulating MT1G and Has an Additive Effect with Doxorubicin in Diffuse Large B-Cell Lymphoma Cells. Heliyon. 2024;10:e28584. https:\/\/doi.org\/10.1016\/J.HELIYON.2024.E28584.","journal-title":"Heliyon"},{"key":"2243_CR9","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/JCMM.14717","volume":"24","author":"S Wei","year":"2019","unstructured":"Wei S, Liu L, Chen Z, Yin W, Liu Y, Ouyang Q, Zeng F, Nie Y, Chen T. Artesunate Inhibits the Mevalonate Pathway and Promotes Glioma Cell Senescence. J Cell Mol Med. 2019;24:276. https:\/\/doi.org\/10.1111\/JCMM.14717.","journal-title":"J Cell Mol Med"},{"key":"2243_CR10","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jphs.2022.01.007","volume":"148","author":"Q Song","year":"2022","unstructured":"Song Q, Peng S, Che F, Zhu X. Artesunate Induces Ferroptosis via Modulation of P38 and ERK Signaling Pathway in Glioblastoma Cells. J Pharmacol Sci. 2022;148:300\u20136. https:\/\/doi.org\/10.1016\/j.jphs.2022.01.007.","journal-title":"J Pharmacol Sci"},{"key":"2243_CR11","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3390\/PHARMACEUTICS17030299","volume":"17","author":"M Shi","year":"2025","unstructured":"Shi M, Ma G, Yang X, Artesunate. A Review of Its Potential Therapeutic Effects and Mechanisms in Digestive Diseases. Pharmaceutics. 2025;17:299. https:\/\/doi.org\/10.3390\/PHARMACEUTICS17030299.","journal-title":"Pharmaceutics"},{"key":"2243_CR12","doi-asserted-by":"publisher","first-page":"121608","DOI":"10.1016\/J.BIOMATERIALS.2022.121608","volume":"287","author":"M Ismail","year":"2022","unstructured":"Ismail M, Yang W, Li Y, Chai T, Zhang D, Du Q, Muhammad P, Hanif S, Zheng M, Shi B. Targeted Liposomes for Combined Delivery of Artesunate and Temozolomide to Resistant Glioblastoma. Biomaterials. 2022;287:121608. https:\/\/doi.org\/10.1016\/J.BIOMATERIALS.2022.121608.","journal-title":"Biomaterials"},{"key":"2243_CR13","doi-asserted-by":"publisher","first-page":"1483049","DOI":"10.3389\/FPHAR.2024.1483049\/FULL","volume":"15","author":"X Fan","year":"2024","unstructured":"Fan X, Yan Y, Li Y, Song Y, Li B. Anti-Tumor Mechanism of Artesunate. Front Pharmacol. 2024;15:1483049. https:\/\/doi.org\/10.3389\/FPHAR.2024.1483049\/FULL.","journal-title":"Front Pharmacol"},{"key":"2243_CR14","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.3390\/MOLECULES29163886","volume":"29","author":"L Wen","year":"2024","unstructured":"Wen L, Chan BCL, Qiu MH, Leung PC, Wong CK. Artemisinin and Its Derivatives as Potential Anticancer Agents. Molecules 2024. 2024;29:3886. https:\/\/doi.org\/10.3390\/MOLECULES29163886.","journal-title":"Molecules 2024"},{"key":"2243_CR15","doi-asserted-by":"publisher","unstructured":"Kisler K, Sagare AP, Lazic D, Bazzi S, Lawson E, Hsu CJ, Wang Y, Ramanathan A, Nelson AR, Zhao Z et al. Anti-Malaria Drug Artesunate Prevents Development of Amyloid-\u03b2 Pathology in Mice by Upregulating PICALM at the Blood-Brain Barrier. Molecular Neurodegeneration 2023 18:1 2023, 18, 7-, https:\/\/doi.org\/10.1186\/S13024-023-00597-5","DOI":"10.1186\/S13024-023-00597-5"},{"key":"2243_CR16","doi-asserted-by":"publisher","first-page":"103867","DOI":"10.1016\/J.REDOX.2025.103867","volume":"87","author":"Y Liu","year":"2025","unstructured":"Liu Y, Yu Y, Luo Z, Fang R, Zhang X, Liao Z, Li W. Artesunate Induces Ferroptosis in Gastric Cancer by Targeting the TFRC-HSPA9 Axis for Iron Homeostasis Regulation. Redox Biol. 2025;87:103867. https:\/\/doi.org\/10.1016\/J.REDOX.2025.103867.","journal-title":"Redox Biol"},{"key":"2243_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/BIOM10121623","volume":"10","author":"D Duarte","year":"2020","unstructured":"Duarte D, Vale N. New Trends for Antimalarial Drugs: Synergism between Antineoplastics and Antimalarials on Breast Cancer Cells. Biomolecules. 2020;10:1\u201320. https:\/\/doi.org\/10.3390\/BIOM10121623.","journal-title":"Biomolecules"},{"key":"2243_CR18","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.31557\/APJCP.2019.20.4.1153","volume":"20","author":"A Khan","year":"2019","unstructured":"Khan A, Aldebasi YH, Alsuhaibani SA, Khan MA. Thymoquinone Augments Cyclophosphamide-Mediated Inhibition of Cell Proliferation in Breast Cancer Cells. Asian Pac J Cancer Prev. 2019;20:1153. https:\/\/doi.org\/10.31557\/APJCP.2019.20.4.1153.","journal-title":"Asian Pac J Cancer Prev"},{"key":"2243_CR19","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1111\/1440-1681.13287","volume":"47","author":"Z Wang","year":"2020","unstructured":"Wang Z, Wang Q, He T, Li W, Liu Y, Fan Y, Wang Y, Wang Q, Chen J. The Combination of Artesunate and Carboplatin Exerts a Synergistic Anti-Tumour Effect on Non-Small Cell Lung Cancer. Clin Exp Pharmacol Physiol. 2020;47:1083\u201391. https:\/\/doi.org\/10.1111\/1440-1681.13287.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2243_CR20","doi-asserted-by":"publisher","first-page":"889971","DOI":"10.3389\/FMOLB.2022.889971","volume":"9","author":"V Pires","year":"2022","unstructured":"Pires V, Bramatti I, Aschner M, Branco V, Carvalho C. Thioredoxin Reductase Inhibitors as Potential Antitumors: Mercury Compounds Efficacy in Glioma Cells. Front Mol Biosci. 2022;9:889971. https:\/\/doi.org\/10.3389\/FMOLB.2022.889971.","journal-title":"Front Mol Biosci"},{"key":"2243_CR21","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.3390\/CANCERS16071321\/S1","volume":"16","author":"JR McCorkle","year":"2024","unstructured":"McCorkle JR, Ahn R, Cao CD, Hill KS, Dietrich CS, Kolesar JM. Antineoplastic Drug Synergy of Artesunate with Navitoclax in Models of High-Grade Serous Ovarian Cancer. Cancers (Basel). 2024;16:1321. https:\/\/doi.org\/10.3390\/CANCERS16071321\/S1.","journal-title":"Cancers (Basel)"},{"key":"2243_CR22","doi-asserted-by":"publisher","first-page":"4735","DOI":"10.3892\/OL.2019.10810\/ABSTRACT","volume":"18","author":"H Li","year":"2019","unstructured":"Li H, Xu K, Pian G, Sun S. Artesunate and Sorafenib: Combinatorial Inhibition of Liver Cancer Cell Growth. Oncol Lett. 2019;18:4735\u201343. https:\/\/doi.org\/10.3892\/OL.2019.10810\/ABSTRACT.","journal-title":"Oncol Lett"},{"key":"2243_CR23","doi-asserted-by":"publisher","unstructured":"Lin W, Wang Y, Li M, Feng J, Yue Y, Yu J, Hu Y, Suo Y. Tumor Treating Fields Enhance Anti-PD Therapy by Improving CCL2\/8 and CXCL9\/CXCL10 Expression through Inducing Immunogenic Cell Death in NSCLC Models. BMC Cancer. 2025;25. https:\/\/doi.org\/10.1186\/S12885-025-13859-W.","DOI":"10.1186\/S12885-025-13859-W"},{"key":"2243_CR24","doi-asserted-by":"publisher","unstructured":"Liu W, Zhou H, Lai W, Hu C, Wang Q, Yuan C, Luo C, Yang M, Hu M, Zhang R et al. Artesunate Induces Melanoma Cell Ferroptosis and Augments Antitumor Immunity through Targeting Ido1. Cell Communication and Signaling 2024 22:1 2024, 22, 378-, https:\/\/doi.org\/10.1186\/S12964-024-01759-8","DOI":"10.1186\/S12964-024-01759-8"},{"key":"2243_CR25","doi-asserted-by":"publisher","first-page":"947530","DOI":"10.3389\/FONC.2022.947530","volume":"12","author":"G Zhang","year":"2022","unstructured":"Zhang G, Fang Y, Li X, Zhang Z, Ferroptosis. A Novel Therapeutic Strategy and Mechanism of Action in Glioma. Front Oncol. 2022;12:947530. https:\/\/doi.org\/10.3389\/FONC.2022.947530.","journal-title":"Front Oncol"},{"key":"2243_CR26","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3892\/OR.2016.5309\/HTML","volume":"37","author":"W Gang","year":"2017","unstructured":"Gang W, Wang JJ, Fu XL, Rui G, Tony To. S.S. Advances in the Targeting of HIF-1\u03b1 and Future Therapeutic Strategies for Glioblastoma Multiforme (Review). Oncol Rep. 2017;37:657\u201370. https:\/\/doi.org\/10.3892\/OR.2016.5309\/HTML.","journal-title":"Oncol Rep"},{"key":"2243_CR27","doi-asserted-by":"publisher","unstructured":"Sun S, Guo C, Gao T, Ma D, Su X, Pang Q, Zhang R. Hypoxia Enhances Glioma Resistance to Sulfasalazine-Induced Ferroptosis by Upregulating SLC7A11 via PI3K\/AKT\/HIF-1 \u03b1 Axis. Oxid. Med. Cell. Longev. 2022, 2022, https:\/\/doi.org\/10.1155\/2022\/7862430","DOI":"10.1155\/2022\/7862430"},{"key":"2243_CR28","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.canlet.2021.12.011","volume":"527","author":"M Li","year":"2022","unstructured":"Li M, Jin S, Zhang Z, Ma H, Yang X. Interleukin-6 Facilitates Tumor Progression by Inducing Ferroptosis Resistance in Head and Neck Squamous Cell Carcinoma. Cancer Lett. 2022;527:28\u201340. https:\/\/doi.org\/10.1016\/j.canlet.2021.12.011.","journal-title":"Cancer Lett"},{"key":"2243_CR29","doi-asserted-by":"publisher","unstructured":"Nie D, Zhang H, Wang H, Song W, Yuan D, Zhu D, Mao G, Guo T, Lin M. Artesunate Triggers Ferroptosis in Ovarian Cancer via GP130-Mediated IL-6\/STAT3\/OTUB1\/SLC711 Axis Disruption. Phytomedicine. 2025;148. https:\/\/doi.org\/10.1016\/j.phymed.2025.157269.","DOI":"10.1016\/j.phymed.2025.157269"},{"key":"2243_CR30","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1002\/STEM.2053","volume":"33","author":"A Hossain","year":"2015","unstructured":"Hossain A, Gumin J, Gao F, Figueroa J, Shinojima N, Takezaki T, Priebe W, Villarreal D, Kang SG, Joyce C, et al. Mesenchymal Stem Cells Isolated From Human Gliomas Increase Proliferation and Maintain Stemness of Glioma Stem Cells Through the IL-6\/Gp130\/STAT3 Pathway. Stem Cells. 2015;33:2400\u201315. https:\/\/doi.org\/10.1002\/STEM.2053.","journal-title":"Stem Cells"},{"key":"2243_CR31","doi-asserted-by":"publisher","unstructured":"Zhou Q, Meng Y, Li D, Yao L, Le J, Liu Y, Sun Y, Zeng F, Chen X, Deng G. Ferroptosis in Cancer: From Molecular Mechanisms to Therapeutic Strategies. Signal Transduction and Targeted Therapy 2024 9:1 2024, 9, 55-, https:\/\/doi.org\/10.1038\/s41392-024-01769-5","DOI":"10.1038\/s41392-024-01769-5"},{"key":"2243_CR32","doi-asserted-by":"publisher","first-page":"274","DOI":"10.7150\/IJBS.10684","volume":"11","author":"S Suman","year":"2015","unstructured":"Suman S, Kallakury BVS, Fornace AJ, Datta K. Protracted Upregulation of Leptin and IGF1 Is Associated with Activation of PI3K\/Akt and JAK2 Pathway in Mouse Intestine after Ionizing Radiation Exposure. Int J Biol Sci. 2015;11:274. https:\/\/doi.org\/10.7150\/IJBS.10684.","journal-title":"Int J Biol Sci"},{"key":"2243_CR33","doi-asserted-by":"publisher","first-page":"102653","DOI":"10.1016\/J.REDOX.2023.102653","volume":"61","author":"F Zeng","year":"2023","unstructured":"Zeng F, Ye L, Zhou Q, He Y, Zhang Y, Deng G, Chen X, Liu H. Inhibiting SCD Expression by IGF1R during Lorlatinib Therapy Sensitizes Melanoma to Ferroptosis. Redox Biol. 2023;61:102653. https:\/\/doi.org\/10.1016\/J.REDOX.2023.102653.","journal-title":"Redox Biol"},{"key":"2243_CR34","doi-asserted-by":"publisher","first-page":"1372330","DOI":"10.3389\/FCELL.2024.1372330","volume":"12","author":"H Su","year":"2024","unstructured":"Su H, Peng C, Liu Y. Regulation of Ferroptosis by PI3K\/Akt Signaling Pathway: A Promising Therapeutic Axis in Cancer. Front Cell Dev Biol. 2024;12:1372330. https:\/\/doi.org\/10.3389\/FCELL.2024.1372330.","journal-title":"Front Cell Dev Biol"},{"key":"2243_CR35","doi-asserted-by":"publisher","first-page":"886","DOI":"10.3390\/BIOM10060886","volume":"10","author":"S Panza","year":"2020","unstructured":"Panza S, Russo U, Giordano F, Leggio A, Barone I, Bonofiglio D, Gelsomino L, Malivindi R, Conforti FL, Naimo GD, et al. Leptin and Notch Signaling Cooperate in Sustaining Glioblastoma Multiforme Progression. Biomolecules. 2020;10:886. https:\/\/doi.org\/10.3390\/BIOM10060886.","journal-title":"Biomolecules"},{"key":"2243_CR36","doi-asserted-by":"publisher","first-page":"878457","DOI":"10.3389\/FIMMU.2022.878457\/FULL","volume":"13","author":"L Zeng","year":"2022","unstructured":"Zeng L, Li SH, Xu SY, Chen K, Qin LJ, Liu XY, Wang F, Fu S, Deng L, Wang FH, et al. Clinical Significance of a CD3\/CD8-Based Immunoscore in Neuroblastoma Patients Using Digital Pathology. Front Immunol. 2022;13:878457. https:\/\/doi.org\/10.3389\/FIMMU.2022.878457\/FULL.","journal-title":"Front Immunol"},{"key":"2243_CR37","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/S00262-014-1651-7","volume":"64","author":"EJ Sayour","year":"2015","unstructured":"Sayour EJ, McLendon P, McLendon R, De Leon G, Reynolds R, Kresak J, Sampson JH, Mitchell DA. Increased Proportion of FoxP3\u2009+\u2009Regulatory T Cells in Tumor Infiltrating Lymphocytes Is Associated with Tumor Recurrence and Reduced Survival in Patients with Glioblastoma. Cancer Immunol Immunother. 2015;64:419. https:\/\/doi.org\/10.1007\/S00262-014-1651-7.","journal-title":"Cancer Immunol Immunother"},{"key":"2243_CR38","doi-asserted-by":"publisher","unstructured":"Han S, Ma E, Wang X, Yu C, Dong T, Zhan W, Wei X, Liang G, Feng S. Rescuing Defective Tumor-Infiltrating T-Cell Proliferation in Glioblastoma Patients. Oncol Lett. 2016;12. https:\/\/doi.org\/10.3892\/OL.2016.4944.","DOI":"10.3892\/OL.2016.4944"},{"key":"2243_CR39","doi-asserted-by":"publisher","first-page":"105","DOI":"10.4103\/0366-6999.147828","volume":"128","author":"CT Tian","year":"2015","unstructured":"Tian CT, Lu SX, Fan QX, Zhang WJ, Jiao SC, Zhao X, Wu ZY, Sun L, Wang LX. Prognostic Significance of Tumor-Infiltrating CD8\u2009+\u2009or CD3\u2009+\u2009T Lymphocytes and Interleukin-2 Expression in Radically Resected Non-Small Cell Lung Cancer. Chin Med J (Engl). 2015;128:105. https:\/\/doi.org\/10.4103\/0366-6999.147828.","journal-title":"Chin Med J (Engl)"},{"key":"2243_CR40","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/J.IMMUNI.2019.12.010","volume":"52","author":"JG Egen","year":"2020","unstructured":"Egen JG, Ouyang W, Wu LC. Human Anti-Tumor Immunity: Insights from Immunotherapy Clinical Trials. Immunity. 2020;52:36\u201354. https:\/\/doi.org\/10.1016\/J.IMMUNI.2019.12.010.","journal-title":"Immunity"},{"key":"2243_CR41","first-page":"361","volume":"140","author":"AS Rathore","year":"2014","unstructured":"Rathore AS, Kumar S, Konwar R, Makker A, Negi MPS, Goel MM, CD3+ CD. CD8\u2009+\u2009Tumour Infiltrating Lymphocytes (TILs) Are Predictors of Favourable Survival Outcome in Infiltrating Ductal Carcinoma of Breast. Indian J Med Res. 2014;140:361.","journal-title":"Indian J Med Res"},{"key":"2243_CR42","doi-asserted-by":"publisher","unstructured":"Liu W, Zhou H, Lai W, Hu C, Wang Q, Yuan C, Luo C, Yang M, Hu M, Zhang R, et al. Artesunate Induces Melanoma Cell Ferroptosis and Augments Antitumor Immunity through Targeting Ido1. Cell Commun Signal. 2024;22. https:\/\/doi.org\/10.1186\/S12964-024-01759-8.","DOI":"10.1186\/S12964-024-01759-8"},{"key":"2243_CR43","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/S12672-025-02567-3","volume":"16","author":"J Pu","year":"2025","unstructured":"Pu J, Yuan K, Tao J, Qin Y, Li Y, Fu J, Li Z, Zhou H, Tang Z, Li L, et al. Glioblastoma Multiforme: An Updated Overview of Temozolomide Resistance Mechanisms and Strategies to Overcome Resistance. Discover Oncol. 2025;16:731. https:\/\/doi.org\/10.1007\/S12672-025-02567-3.","journal-title":"Discover Oncol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02243-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02243-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02243-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:23:41Z","timestamp":1791329021000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-026-02243-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,12]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2243"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02243-y","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,12]]},"assertion":[{"value":"17 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were conducted in accordance with guidelines set forth by the Institutional Animal Ethics Committee (IAEC) of St. Pauls College of Pharmacy, Hyderabad, India, under approval number SPSCP\/COL\/2022-23\/001. The animal study was reported in accordance with the ARRIVE guidelines.","order":2,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"348"}}